Implementation challenges of eliminating preferential currency in Iran’s pharmaceutical sector

Before the implementation of Darooyar, Iran’s pharmaceutical sector relied heavily on preferential foreign-exchange allocation for imported medicines and pharmaceutical inputs, while the system faced broader challenges related to financing, affordability, and medicine supply. In this context, the Darooyar plan was introduced to eliminate preferential currency and replace it with a targeted pharmaceutical subsidy mechanism intended to improve the sustainability and transparency of pharmaceutical financing. This study aimed to explore the challenges associated with eliminating preferential currency in Iran’s pharmaceutical sector, with particular attention to financing, governance, stakeholder relationships, and pharmaceutical supply-chain pressures. A qualitative study employing descriptive content analysis was conducted in 2025 to explore the challenges associated with eliminating preferential currency in Iran’s pharmaceutical sector, with particular attention to financing, governance, stakeholder relationships, and pharmaceutical supply-chain pressures. Participants included policymakers, executive managers, insurance specialists, pharmacy technical officers, and pharmaceutical manufacturers. Purposive sampling with a snowball approach was applied, yielding 27 participants. Data were collected through semi-structured interviews using an interview guide. Data collection and analysis were performed concurrently using Atlas.ti software. Five overarching themes, 21 subthemes, and 73 codes were identified regarding the challenges of implementing the policy. The main themes comprised: (1) Weaknesses in policy design, management, planning, and implementation; (2) Reported irregularities, misconduct, and inadequate oversight within the pharmaceutical system; (3) stakeholder dissatisfaction and constraints; (4) financial problems across the pharmaceutical supply chain; and (5) Macroeconomic and policy pressures on pharmaceutical system sustainability. Recommendations include strengthening technological infrastructure (integrated insurance systems and reliable internet), targeted education and communication, establishing independent expert oversight, ensuring sustainable budget allocation with timely online payments, and conducting pilot implementations with continuous evaluation prior to nationwide rollout.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-16
DOI
https://doi.org/10.1038/s41598-026-79155-0
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Implementation challenges of eliminating preferential currency in Iran’s pharmaceutical sector

Mohsen Bayati, Seyyed Morteza Mojtabaeian, Mohammad Javad Taghipour, Sajad Delavari et al.
3 links
Scientific Reports
Pharmaceutical Economics and Policy
article

Implementation challenges of eliminating preferential currency in Iran’s pharmaceutical sector

Mohsen Bayati, Seyyed Morteza Mojtabaeian, Mohammad Javad Taghipour, Sajad Delavari, Farhad Lotfi
article en

Abstract

Before the implementation of Darooyar, Iran’s pharmaceutical sector relied heavily on preferential foreign-exchange allocation for imported medicines and pharmaceutical inputs, while the system faced broader challenges related to financing, affordability, and medicine supply. In this context, the Darooyar plan was introduced to eliminate preferential currency and replace it with a targeted pharmaceutical subsidy mechanism intended to improve the sustainability and transparency of pharmaceutical financing. This study aimed to explore the challenges associated with eliminating preferential currency in Iran’s pharmaceutical sector, with particular attention to financing, governance, stakeholder relationships, and pharmaceutical supply-chain pressures. A qualitative study employing descriptive content analysis was conducted in 2025 to explore the challenges associated with eliminating preferential currency in Iran’s pharmaceutical sector, with particular attention to financing, governance, stakeholder relationships, and pharmaceutical supply-chain pressures. Participants included policymakers, executive managers, insurance specialists, pharmacy technical officers, and pharmaceutical manufacturers. Purposive sampling with a snowball approach was applied, yielding 27 participants. Data were collected through semi-structured interviews using an interview guide. Data collection and analysis were performed concurrently using Atlas.ti software. Five overarching themes, 21 subthemes, and 73 codes were identified regarding the challenges of implementing the policy. The main themes comprised: (1) Weaknesses in policy design, management, planning, and implementation; (2) Reported irregularities, misconduct, and inadequate oversight within the pharmaceutical system; (3) stakeholder dissatisfaction and constraints; (4) financial problems across the pharmaceutical supply chain; and (5) Macroeconomic and policy pressures on pharmaceutical system sustainability. Recommendations include strengthening technological infrastructure (integrated insurance systems and reliable internet), targeted education and communication, establishing independent expert oversight, ensuring sustainable budget allocation with timely online payments, and conducting pilot implementations with continuous evaluation prior to nationwide rollout.

Scientific Reports
Shiraz University of Medical Sciences (IR)
National Institute for Health and Care Excellence, Shiraz University of Medical Sciences
Good health and well-being
Pharmaceutical Economics and Policy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon